Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
Polish version English version Language
enabled [disable] Abstract
Number of results

Results found: 2

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Content available remote

Erratum to: “Synthesis and characterization of molecularly imprinted polymer for controlled release of tramadol”

100%
Azodi-Deilami S., Abdouss M., Rezvaneh Seyedi S.
Open Chemistry
|
2011
|
vol. 9
|
issue 3
499-499
EN
The original version of the article was published in Cent. Eur. J. Chem., Vol. 8(3), (2010), pp. 687–695. Unfortunately, the original version of this article contains mistakes in the Authors names section. There should be: Saman Azodi-Deilami1, Majid Abdouss1 and S. Rezvaneh Seyedi2.
2
Content available remote

Preparation and utilization of a molecularly imprinted polymer for solid phase extraction of tramadol

100%
Azodi-Deilami S., Abdouss M., Hasani S.
Open Chemistry
|
2010
|
vol. 8
|
issue 4
861-869
EN
In this paper, a highly selective molecularly imprinted polymer (MIP) for tramadol hydrochloride, a drug used to treat moderate to severe pain, was prepared and its use as solid-phase extraction (SPE) sorbent was demonstrated. The molecularly imprinted solid-phase extraction procedure followed by high performance liquid chromatography with ultraviolet detector (MISPE-HPLC) was developed for selective extraction and determination of tramadol in human plasma and urine. The optimal conditions for molecularly imprinted solid-phase extraction (MISPE) consisted of conditioning with 1 mL methanol and 1 mL of deionized water at neutral pH, loading of tramadol sample (50 µg L−1) at pH 7.5, washing using 1 mL acetone and elution with 3 × 1 mL of 10% (v/v) acetic acid in methanol. The MIP selectivity was evaluated by checking several substances with similar molecular structures to that of tramadol. Results from the HPLC analyses showed that the calibration curve of tramadol (using MIP from human plasma and urine) is linear in the ranges of 6–100 and 3–120 µg L−1 with good precisions (1.9% and 2.9% for 5.0 µg L−1), respectively. The recoveries for plasma and urine samples were higher than 81%. [...]
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.